Increased urinary cGMP and decreased albumin excretion with isradipine treatment in essential hypertension

Cardiovasc Drugs Ther. 1997 Nov;11(5):651-2. doi: 10.1023/a:1007782807263.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Albumins / metabolism*
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / therapeutic use*
  • Cyclic GMP / urine*
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / urine
  • Isradipine / therapeutic use*
  • Male

Substances

  • Albumins
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Cyclic GMP
  • Isradipine